{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:07:38Z","timestamp":1791504458842,"version":"4.3.4"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>Human papillomavirus (HPV) is essential for developing cervical cancer and precancerous lesions. Currently, three vaccines are available, which are effective as prophylaxis against HPV infection, however, limited knowledge exists about the possible effect of vaccinating women treated with conization to prevent recurrence. The aim of our study was to examine the risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) after conization according to HPV vaccination status. Using Danish nationwide registries, we identified women diagnosed with CIN3 on the cone (2006\u20132012) and their HPV vaccination status. Vaccinees were defined as women vaccinated between 3 months before until 1 year after conization. The women were followed from 1\u2009year after conization until diagnosis of CIN2+, conization, death, emigration or end of follow\u2010up. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) of CIN2+ comparing vaccinees with nonvaccinees. The HR was adjusted for age, histology on cone, education, year of conization, repeat conizations and CIN2+ lesions between conization and start of follow\u2010up. Altogether 17,128 women were included (2,074 vaccinees). There was a statistically nonsignificant lower risk of CIN2+ among vaccinees (HR<jats:sub>adjusted<\/jats:sub> = 0.86, 95% CI: 0.67\u20131.09). Women vaccinated 0\u20133 months before tended to have a slightly lower HR of CIN2+ (HR<jats:sub>adjusted<\/jats:sub> = 0.77, 95% CI: 0.45\u20131.32) than women vaccinated 0\u201312\u2009months after conization (HR<jats:sub>adjusted<\/jats:sub> = 0.88, 95% CI: 0.67\u20131.14), although not statistically significantly different. Our results add to the current knowledge about the potential clinical effect of vaccination as an adjunct to conization of high\u2010grade cervical neoplasia to decrease risk of recurrence.<\/jats:p>","DOI":"10.1002\/ijc.32752","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T18:01:14Z","timestamp":1571940074000},"page":"641-647","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status"],"prefix":"10.1002","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-8557","authenticated-orcid":false,"given":"Freja L.","family":"Sand","sequence":"first","affiliation":[{"name":"Unit of Virus, Lifestyle and Genes Danish Cancer Society Research Center  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne K.","family":"Kjaer","sequence":"additional","affiliation":[{"name":"Unit of Virus, Lifestyle and Genes Danish Cancer Society Research Center  Copenhagen Denmark"},{"name":"Department of Gynecology Rigshospitalet, University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-6613","authenticated-orcid":false,"given":"Kirsten","family":"Frederiksen","sequence":"additional","affiliation":[{"name":"Unit of Statistics and Pharmacoepidemiology Danish Cancer Society Research Center  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6161-4565","authenticated-orcid":false,"given":"Christian","family":"Dehlendorff","sequence":"additional","affiliation":[{"name":"Unit of Statistics and Pharmacoepidemiology Danish Cancer Society Research Center  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn036"},{"key":"e_1_2_8_3_1","unstructured":"European Medicines Agency. European public assessment report for Cervarix. Available from:http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000721\/human_med_000694.jsp&mid=WC0b01ac058001d125&murl=menus\/medicines\/medicines.jsp. Accessed October 12 2016."},{"key":"e_1_2_8_4_1","unstructured":"European Medicines Agency. European public assessment report for Gardasil. Available from:http:\/\/www.emea.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000703\/human_med_000805.jsp. Accessed October 11 2016."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.097"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60852-6"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt460"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31202"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30391"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.04.050"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1401"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.08.033"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.02.021"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810393563"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811405098"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394718"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394717"},{"key":"e_1_2_8_20_1","unstructured":"The Danish National Board of Health. Screening for livmoderhalskr\u00e6ft\u2014anbefalinger 2007. Available from:https:\/\/sundhedsstyrelsen.dk\/publ\/Publ2007\/SYB\/Kraeft\/ScreenLivmoderhalskrftAnbef.pdf.2007. Accessed March 20 2017."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12116"},{"key":"e_1_2_8_22_1","unstructured":"The Danish National Board of Health. Screening for livmoderhalskr\u00e6ft\u2014anbefalinger 2012. Available from:https:\/\/sundhedsstyrelsen.dk\/publ\/Publ2012\/SYB\/Kraeft\/ScreenLivmoderhalskrftAnbef.pdf.2012. Accessed March 20 2017."},{"key":"e_1_2_8_23_1","first-page":"141","article-title":"Empirical transition matrix for non\u2010homogenous Markov\u2010chains based on censored observations","volume":"5","author":"Aalen O","year":"1978","journal-title":"Scand J Stat"},{"key":"e_1_2_8_24_1","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2016"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v038.i04"},{"key":"e_1_2_8_26_1","volume-title":"Modeling survival data: extending the cox model","author":"Terry T","year":"2000"},{"key":"e_1_2_8_27_1","unstructured":"CarstensenB PlummerM LaaraE et al. Epi: A package for statistical analysis in epidemiology. R package version 2.19.2017. Available from:https:\/\/CRAN.R-project.org\/package=Epi."},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2872"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.5.10.9515"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26362"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1036"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.32752","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ijc.32752","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.32752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:32:13Z","timestamp":1693999933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.32752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/ijc.32752"],"URL":"https:\/\/doi.org\/10.1002\/ijc.32752","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"2019-01-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}